| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |